This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Emergent BioSolutions is selling a manufacturing site in Baltimore — which has a...
Compounding pharmacies faced a major setback in their case over the FDA’s decisi...
Emergent is selling a manufacturing site in Baltimore — which has a history of c...
Beam Therapeutics said its experimental gene editing treatment helped lower leve...
At this year’s American Academy of Dermatology annual meeting, companies like Am...
The FDA told staff on Monday that reviewers of medical products and inspectors o...
Novo Nordisk’s late-stage weight loss data showed CagriSema performed below anal...
Johnson & Johnson and Protagonist Therapeutics have bet their oral IL-23 drug wi...
Trevi Therapeutics’ chronic cough drug reduced patients’ 24-hour cough frequency...
Arrowhead Pharmaceuticals on Monday shared new open-label data in about a dozen ...
Nosis Bio, a startup developing new ways to deliver RNA therapies to specific ce...
Novo Nordisk’s CagriSema demonstrated weight loss of 15.7% in patients with both...
After months of searching for a partner for its recently approved cancer drug, C...
Topline pivotal data suggest that Mineralys Therapeutics’ experimental hypertens...
Nosis Bio, a startup developing new ways to deliver RNA therapies to specific ce...
Welcome back to Endpoints Weekly! This week was another busy one in DC, with two...